PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Results from WEARIT-II Registry of Wearable Cardioverter Defibrillator Usage to be Presented at Heart Rhythm 2013 - ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that results from the Prospective Registry and Follow-Up of Patients Using the Wearable Defibrillator (WEARIT-II)
Results from WEARIT-II Registry of Wearable Cardioverter Defibrillator Usage to be Presented at Heart Rhythm 2013

 

NewswireToday - /newswire/ - Chelmsford, MA, United States, 2013/04/29 - ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that results from the Prospective Registry and Follow-Up of Patients Using the Wearable Defibrillator (WEARIT-II) . NASDAQ: ZOLL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that results from the Prospective Registry and Follow-Up of Patients Using the Wearable Defibrillator (WEARIT-II) will be presented in a Late-Breaking Clinical Trial presentation at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, Friday, May 10, 1:30-3:00 pm., Session number SP22.

The 18-month results from WEARIT-II will be presented by Ilan Goldenberg, MD, (Principal Investigator) University of Rochester Medical Center. WEARIT-II is a prospective, observational study designed to evaluate high cardiac risk patients’ clinical information, arrhythmias, and treatment findings during wearable defibrillator use and subsequent one-year clinical course, including survival.

“As an investigator in the original WEARIT/BIROAD clinical trial and the co-principal investigator for the WEARIT-II Registry, it is rewarding to see that these data will be shared as part of the Late-Breaking Clinical Trial presentations at Heart Rhythm. The LifeVest® plays an important role in the continuum of care for patients at high risk from sudden cardiac arrest,” said Arthur J. Moss, MD, University of Rochester Medical Center. “The LifeVest allows physicians to protect patients during their period of highest risk early after an acute cardiac event such as a myocardial infarction or newly diagnosed nonischemic cardiomyopathy, when other therapies are not appropriate due to the patient’s changing condition and the potential for cardiac recovery.”

“WEARIT-II is the first multi-national registry of LifeVest usage and is currently enrolling patients in the U.S., Europe, and Israel. We look forward to this presentation of the 18-month U.S. results,” said Marshal Linder, President of ZOLL LifeVest. “These data will add to our understanding of the real-world treatment approaches and outcomes from physicians’ utilization of wearable defibrillators.”

The LifeVest Wearable Defibrillator, along with sudden cardiac arrest (SCA) education and screening tools, will be on display in Booth #539 at Heart Rhythm 2013 May 8-11 at the Colorado Convention Center in Denver.
LifeVest Provides Protection for Patients at Risk of SCA

The LifeVest Wearable Defibrillator protects patients at risk for sudden cardiac arrest. It is used to protect a wide range of patients, including patients with newly diagnosed heart failure, following recent myocardial infarction, or following coronary revascularization. The LifeVest provides protection during this period of high risk, gives physicians time to optimize medical therapy, and helps ensure patients are not lost to follow up.

The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. The LifeVest continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm.

The LifeVest is covered by most health plans in the United States, including commercial, state, and federal plans.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.

About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

Copyright © 2013 ZOLL Medical Corporation. All rights reserved. LifeVest and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. All product names are the property of their respective owners. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All trademarks are the property of their respective owners.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ZOLL Medical Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Results from WEARIT-II Registry of Wearable Cardioverter Defibrillator Usage to be Presented at Heart Rhythm 2013

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Diane Egan - ZOLL.com 
978-421-9637 degan[.]zoll.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ZOLL Medical Corporation / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)